Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.